TD Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

TD Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-103,298	Closed	-$1.51M	–	1578
2020 Q4	$1.51M	Buy	103,298 +16,000	+18%	+$212K	﹤0.01%	1098
2020 Q3	$1.24M	Sell	87,298 -18,700	-18%	-$286K	﹤0.01%	1039
2020 Q2	$1.56M	Hold	105,998	–	–	﹤0.01%	941
2020 Q1	$437K	Hold	105,998	–	–	﹤0.01%	1200
2019 Q4	$510K	Sell	105,998 -33,800	-24%	-$186K	﹤0.01%	1241
2019 Q3	$847K	Sell	139,798 -12,418	-8%	-$77.5K	﹤0.01%	1087
2019 Q2	$988K	Sell	152,216 -100	-0.1%	-$705	﹤0.01%	1054
2019 Q1	$1.08M	Sell	152,316 -5,500	-3%	-$36.2K	﹤0.01%	1027
2018 Q4	$767K	Sell	157,816 -31,800	-17%	-$166K	﹤0.01%	1120
2018 Q3	$1.39M	Buy	189,616 +8,600	+5%	+$63.1K	﹤0.01%	1077
2018 Q2	$1.16M	Buy	181,016 +2,400	+1%	+$15.9K	﹤0.01%	1099
2018 Q1	$972K	Buy	178,616 +4,100	+2%	+$20.4K	﹤0.01%	1067
2017 Q4	$728K	Buy	174,516 +44,236	+34%	+$266K	﹤0.01%	1125
2017 Q3	$1.25M	Buy	130,280 +15,812	+14%	+$164K	﹤0.01%	978
2017 Q2	$1.35M	Buy	114,468 +12,394	+12%	+$158K	﹤0.01%	972
2017 Q1	$1.31M	Buy	102,074 +3,074	+3%	+$37K	﹤0.01%	976
2016 Q4	$1.21M	Hold	99,000	–	–	﹤0.01%	976
2016 Q3	$1.17M	Buy	99,000 +48,800	+97%	+$471K	﹤0.01%	977
2016 Q2	$437K	Sell	50,200 -800	-2%	-$5.49K	﹤0.01%	1156
2016 Q1	$269K	Sell	51,000 -100	-0.2%	-$557	﹤0.01%	1249
2015 Q4	$397K	Sell	51,100 -2,500	-5%	-$19.2K	﹤0.01%	1164
2015 Q3	$422K	Buy	53,600 +1,700	+3%	+$15.7K	﹤0.01%	1109
2015 Q2	$470K	Buy	51,900 +400	+0.8%	+$4.03K	﹤0.01%	1133
2015 Q1	$668K	Hold	51,500	–	–	﹤0.01%	1053
2014 Q4	$701K	Hold	51,500	–	–	﹤0.01%	1013
2014 Q3	$462K	Hold	51,500	–	–	﹤0.01%	1059
2014 Q2	$697K	Hold	51,500	–	–	﹤0.01%	963
2014 Q1	$512K	Buy	51,500 +3,400	+7%	+$42.2K	﹤0.01%	1033
2013 Q4	$640K	Sell	48,100 -25,800	-35%	-$313K	﹤0.01%	953
2013 Q3	$898K	Buy	73,900 +13,400	+22%	+$144K	﹤0.01%	886
2013 Q2	$626K	Buy	+60,500	New	+$834K	﹤0.01%	900

Other funds holding GNMK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Asset Management's GNMK Position: Q1 2021 in Review

TD Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 103,298 shares — an estimated $1.51M sold.

TD Asset Management first reported a position in GNMK in Q2 2013 and held it in 31 quarters. The position peaked at $1.56M in Q2 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

TD Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
TD Asset Management sold 103,298 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $1.51M.
TD Asset Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 31 quarters.
TD Asset Management's GenMark Diagnostics, Inc position peaked at $1.56M in Q2 2020.
164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on TD Asset Management's 13F filing for Q1 2021, filed 14 May 2021.